Scholars Central

Conference abstractPublished 2018

Tracking glioma progression by genetic barcoding

Authors: Ceresa Davide, Alessandrini Francesco, Appolloni Irene, Malatesta Paolo

Università degli studi di Genova, Italy IRCCS AOU San Martino, Italy

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

During tumor progression, transformed cells accumulate mutations and gain malignancy. By now, it is unclear how easily this process can be undertaken and if it can be considered the main bottleneck in tumorigenesis. To measure the probability of glioma progression, we used a well-characterized murine model of gliomagenesis, induced by overexpressing PDGF-B in embryonic Neural Progenitor Cells (NPC), mimicking a possible first hit of tumorigenesis. In order to univocally tag each PDGF-transduced cell, we added a degenerated barcode sequence to the PDGF-B transducing vector and we produced high complexity libraries of barcoded retroviruses that had been injected in mouse embryos. After the development of gliomas, tumor masses were analyzed by NGS and compared to embryonic brains few days post infection. By using in-house developed software, we successfully retrieved barcodes from tumor masses and reconstructed the clonal composition of several independent tumors in different progression stages. Our data shows that even though low grade, partially progressed tumor masses are clonally heterogeneous and composed by about one thousand independent clones each, they are the result of a strong selection because the number of oncogene-transduced cells is more than 10 times higher. Still, high grade and fully progressed gliomas are characterized by a very low clonal complexity and often are composed by a single clone, suggesting another great bottleneck in glioma progression divides these two stages. More strikingly, fully progressed tumors derived from in vivo transplant the same pool of thousands different transduced NPCs are composed by the same clones, suggesting that a predetermined cell state is required to gain malignancy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Clinical & Experimental Oncology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Oncology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Ceresa Davide”
  • BylineArticles whose byline prints “Alessandrini Francesco”
  • BylineArticles whose byline prints “Appolloni Irene”
  • BylineArticles whose byline prints “Malatesta Paolo”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels